Adults with type 2 diabetes may have lower risk for fractures if they use semaglutide compared with other medications, according to data presented at ENDO 2026. As Healio previously reported, a ...
As published in Behavioural Pharmacology, two days of PT00114 treatment reduced corticosterone levels and attenuated anxiety-like behavior in chronically stressed rats; a known CRF₁ receptor ...
VRBPAC endorsed mRNA-1010 for adults 50-64 and ≥65 years, unanimously concluding benefits outweighed risks, supporting a late-stage regulatory path toward potential first mRNA seasonal influenza ...
A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded ...
NovaBridge (NBP) is rated Sell due to limited market opportunity, intense competition, and high cash burn overshadowing its ...
GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.
No vaccine-related serious adverse events (SAEs) or sustained Grade 3 or higher adverse events related to the vaccine reportedSOUTH SAN ...
You may be excited to learn that Whistler councillors have approved a pay bump for the next term. At its June 23 meeting, ...
School-based programmes may prevent adolescents from starting to use electronic cigarettes (e-cigarettes) and a community-based programme delivered by text message probably helps adolescents quit ...
Many of the FDA’s decisions this quarter involve applications that have previously been delayed, declined or outright ...
Cannabinoid therapies may alleviate agitation in Alzheimer disease, though somnolence remains a primary safety concern.
No significant difference in the risk for serious infections in patients with psoriasis was noted among most systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results